GE HealthCare Technologies (GEHC) Projected to Release Quarterly Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) is projected to issue its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect GE HealthCare Technologies to announce earnings of $1.04 per share and revenue of $5.2644 billion for the quarter. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Investors can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.01 earnings per share. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $62.04 on Wednesday. The stock’s 50 day moving average is $63.66 and its 200 day moving average is $71.60. GE HealthCare Technologies has a one year low of $58.75 and a one year high of $89.77. The firm has a market cap of $28.22 billion, a P/E ratio of 14.84, a P/E/G ratio of 1.71 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on GEHC. HSBC dropped their price target on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Wells Fargo & Company decreased their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. UBS Group lowered their target price on shares of GE HealthCare Technologies from $69.00 to $67.00 and set a “neutral” rating for the company in a research note on Thursday, July 16th. Citigroup restated a “neutral” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. Finally, Argus cut their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. Ten research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $76.41.

Insider Activity

In related news, Director Kevin Lobo acquired 10,000 shares of the stock in a transaction dated Friday, May 22nd. The stock was bought at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director directly owned 14,363 shares of the company’s stock, valued at $921,817.34. The trade was a 229.20% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Rodney F. Hochman bought 1,618 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the transaction, the director directly owned 1,618 shares in the company, valued at $100,364.54. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders purchased 21,847 shares of company stock worth $1,361,355. Company insiders own 0.36% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of large investors have recently bought and sold shares of the stock. Lbmc Investment Advisors LLC bought a new stake in GE HealthCare Technologies in the 4th quarter valued at about $207,000. Keel Point LLC acquired a new position in GE HealthCare Technologies during the 4th quarter worth approximately $200,000. UMB Bank n.a. boosted its holdings in GE HealthCare Technologies by 36.0% in the fourth quarter. UMB Bank n.a. now owns 1,969 shares of the company’s stock worth $161,000 after acquiring an additional 521 shares in the last quarter. Ameriflex Group Inc. boosted its holdings in GE HealthCare Technologies by 146.0% in the fourth quarter. Ameriflex Group Inc. now owns 1,358 shares of the company’s stock worth $111,000 after acquiring an additional 806 shares in the last quarter. Finally, Rowlandmiller & PARTNERS.ADV acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $106,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.